Forxiga® (dapagliflozin) tablets for type 2 diabetes, heart failure, and CKD

What Forxiga® Is and How It Works

Forxiga® (dapagliflozin) is an oral SGLT2 inhibitor used for type 2 diabetes, heart failure, and chronic kidney disease. It helps the kidneys remove excess glucose and sodium in urine. Typical strengths are 5 mg and 10 mg once daily. Many compare forxiga price and options such as forxiga without insurance when planning therapy.

CanadianInsulin is a prescription referral service. Prescriptions are verified with your clinic, and orders are filled by licensed Canadian pharmacies. We work with licensed and vetted partner pharmacies, offering authentic brand medications and value‑focused pricing.

In type 2 diabetes, dapagliflozin lowers A1C, reduces fasting and post‑meal glucose, and may reduce weight and blood pressure. In heart failure (reduced or preserved ejection fraction), it lowers the risk of hospitalization and cardiovascular death. In chronic kidney disease, it slows eGFR decline and reduces the risk of kidney failure.

Forxiga is taken by mouth, with or without food, and is made by AstraZeneca. If you want to learn more about clinical uses, see our article What Is Farxiga Used For Understanding Its Benefits In Diabetes And Beyond. You can also browse our Heart Failure condition page for related treatments.

Dosage and Usage

• Starting dose: 5 mg once daily for type 2 diabetes; 10 mg once daily is often used for heart failure and CKD.
• Titration: Increase from 5 mg to 10 mg once daily if additional effect is needed and tolerated.
• Administration: Swallow the tablet whole at about the same time each day, with or without food.
• Missed dose: Take as soon as you remember the same day. Skip if it is almost time for the next dose. Do not double doses.
• Renal function: Glycemic effect lessens with lower eGFR. Heart failure and CKD benefits may still apply at lower eGFR per labeling.
• Concomitant medications: A lower dose of insulin or a sulfonylurea may be needed to reduce hypoglycemia risk.

• Storage: Keep tablets at 20–25°C (68–77°F); excursions 15–30°C (59–86°F).
• Packaging: Store in original bottle or blister to protect from moisture.
• Travel: Carry in hand luggage. Bring enough tablets plus a few extra days’ supply.
• Handling: Keep dry; do not split or crush unless your clinician advises.
• Disposal: Follow local guidance for unused or expired tablets.

Benefits and Savings

Dapagliflozin improves glycemic control (average A1C reduction about 0.5–1%). Modest weight loss (often 2–3 kg over time) and small blood pressure reductions are common. In heart failure, Forxiga reduces hospitalizations across EF ranges. In CKD, it slows the decline of kidney function and reduces kidney failure risk.

Convenience includes once‑daily dosing and tablet portability. Many patients compare forxiga cost, forxiga 10mg price, or forxiga 5 mg price to plan budgets. Typical customers report 60–80% savings versus US retail when ordering through Canadian pharmacies. Savings can help those looking for options forxiga without insurance or a competitive forxiga cash price.

See our promotions page for current offers, including any forxiga coupon if available.

People searching for discount forxiga, wholesale forxiga, or forxiga online can compare options here. We also provide information on forxiga used for diabetes, heart failure, and CKD, and how the forxiga 10 mg cost compares with 5 mg.

Side Effects and Safety

• Common: Genital yeast infections, urinary tract infections, increased urination, thirst, runny nose, nausea, constipation, or back pain.
• Metabolic/renal: Volume depletion, dizziness, low blood pressure (especially in the elderly or those on diuretics).
• Laboratory: Modest initial eGFR dip, which typically stabilizes.
• Weight/BP: Modest weight loss and small blood pressure reductions.
• Hypoglycemia: Risk increases when used with insulin or sulfonylureas; dose adjustments of those agents may be needed.

Serious but less common risks include diabetic ketoacidosis (including euglycemic DKA, which may present with nausea, vomiting, abdominal pain, and fatigue), acute kidney injury, severe urinary infections (pyelonephritis/urosepsis), and rare cases of necrotizing fasciitis of the perineum (Fournier’s gangrene). Seek urgent care if severe symptoms occur or ketones are elevated.

Onset Time

Glycemic effects begin within the first 1–2 weeks, with A1C reductions becoming more apparent over 8–12 weeks and stabilizing by about 24 weeks. Blood pressure changes may be seen within weeks. Weight changes are gradual over several months. In heart failure, risk reduction for hospitalization can emerge within weeks and accumulates over months of continuous therapy.

Compare With Alternatives

Within the SGLT2 class, Jardiance® (empagliflozin) is a close alternative with similar heart failure and CKD benefits. Choice may depend on clinical history, kidney function thresholds, and formulary access. Discuss prior intolerance, infections, and diuretic use when comparing agents.

Invokana® (canagliflozin) is another SGLT2 option. It offers glycemic, renal, and cardiovascular benefits, though labeling and adverse event profiles differ by agent. Individual risk factors and medication history help guide selection.

Some patients and clinicians consider GLP‑1 therapies for added A1C and weight effects. Oral Rybelsus® (semaglutide) or weekly Trulicity® (dulaglutide) may be paired with or chosen instead of an SGLT2 inhibitor depending on goals and tolerability.

For heart failure optimization, other disease‑modifying options may be considered alongside or instead of an SGLT2 inhibitor, such as the mineralocorticoid receptor antagonist Spironolactone or ACE‑inhibitor and diuretic combinations like Ramipril Hctz. These choices depend on ejection fraction, blood pressure, and renal function.

Combination Therapy

• Metformin plus dapagliflozin for foundational glycemic control in type 2 diabetes.
• GLP‑1 receptor agonist plus SGLT2 inhibitor for added A1C reduction and weight benefits.
• DPP‑4 inhibitor combinations if GLP‑1 is not suitable.
• Basal insulin with SGLT2 inhibitor; consider lowering insulin dose to reduce hypoglycemia risk.
• Heart failure regimens may include beta‑blocker, ACE inhibitor/ARB/ARNI, MRA, and loop diuretic along with dapagliflozin.

Patient Suitability and Cost‑Saving Tips

Forxiga is used for adults with type 2 diabetes, heart failure across EF ranges, and chronic kidney disease. It is not indicated for type 1 diabetes. It is not recommended in pregnancy or during breastfeeding unless benefits outweigh risks. Evaluate candidacy if you have recurrent genital infections, frequent UTIs, or a history of ketoacidosis.

Kidney function matters. Glycemic efficacy declines at lower eGFR, but heart failure and CKD benefits may persist at lower thresholds per labeling. Monitor volume status, especially if you use diuretics or have low blood pressure.

People often ask about forxiga 10 mg for heart failure dosing or whether forxiga 10 mg weight loss results are typical. Weight changes are modest and Forxiga is not a weight‑loss drug, including in non‑diabetics. Those comparing forxiga 10 mg cost vs. 5 mg can review current options before ordering.

Cost‑saving tips: consider multi‑month quantities, compare forxiga cost across strengths, and time reorders to avoid last‑minute retail purchases. If affordability is a concern, you can explore options for forxiga without insurance through Canadian pricing and promotions.

Authoritative Sources

AstraZeneca Forxiga (dapagliflozin) product information

Health Canada Drug Product Database: Dapagliflozin

FDA Prescribing Information: FARXIGA (dapagliflozin)

Order Forxiga® from CanadianInsulin: add to cart, upload your prescription, and we ship with prompt, express, cold‑chain handling.

This content is educational and not a substitute for professional medical advice. Always consult your healthcare provider about diagnosis, treatment, and dosing choices.